AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
LONG-TERM OUTCOME AFTER MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA
Authors: DEEG HJ LEISENRING W STORB R NIMS J FLOWERS MED WITHERSPOON RP SANDERS J SULLIVAN KM
Citation: Hj. Deeg et al., LONG-TERM OUTCOME AFTER MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA, Blood, 91(10), 1998, pp. 3637-3645
WEIGHT-LOSS, SKIN RASH, AND COUGH FOLLOWING BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: WITHERSPOON RP MCGLAVE P CAMPBELL JB ROLSTON KVI
Citation: Rp. Witherspoon et al., WEIGHT-LOSS, SKIN RASH, AND COUGH FOLLOWING BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Cancer practice, 6(4), 1998, pp. 202-205
IGG RESPONSE TO PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE APPEARSSIMILAR TO IGG RESPONSE TO POLYSACCHARIDE IN BONE-MARROW TRANSPLANT RECIPIENTS AND HEALTHY-ADULTS
Authors: STOREK J MENDELMAN PM WITHERSPOON RP MCGREGOR BA STORB R
Citation: J. Storek et al., IGG RESPONSE TO PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE APPEARSSIMILAR TO IGG RESPONSE TO POLYSACCHARIDE IN BONE-MARROW TRANSPLANT RECIPIENTS AND HEALTHY-ADULTS, Clinical infectious diseases, 25(5), 1997, pp. 1253-1255
INFECTIOUS MORBIDITY IN LONG-TERM SURVIVORS OF ALLOGENEIC MARROW TRANSPLANTATION IS ASSOCIATED WITH LOW CD4 T-CELL COUNTS
Authors: STOREK J GOOLEY T WITHERSPOON RP SULLIVAN KM STORB R
Citation: J. Storek et al., INFECTIOUS MORBIDITY IN LONG-TERM SURVIVORS OF ALLOGENEIC MARROW TRANSPLANTATION IS ASSOCIATED WITH LOW CD4 T-CELL COUNTS, American journal of hematology, 54(2), 1997, pp. 131-138
SOLID CANCERS AFTER BONE-MARROW TRANSPLANTATION
Authors: CURTIS RE ROWLINGS PA DEEG HJ SHRINER DA SOCIE G TRAVIS LB HOROWITZ MM WITHERSPOON RP HOOVER RN SOBOCINSKI KA FRAUMENI JF BOICE JD
Citation: Re. Curtis et al., SOLID CANCERS AFTER BONE-MARROW TRANSPLANTATION, The New England journal of medicine, 336(13), 1997, pp. 897-904
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION MAY BE ASSOCIATED WITH A HIGH-RISK OF CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: STOREK J GOOLEY T SIADAK M BENSINGER WI MALONEY DG CHAUNCEY TR FLOWERS M SULLIVAN KM WITHERSPOON RP ROWLEY SD HANSEN JA STORB R APPELBAUM FR
Citation: J. Storek et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION MAY BE ASSOCIATED WITH A HIGH-RISK OF CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 90(12), 1997, pp. 4705-4709
MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION
Authors: SLATTERY JT CLIFT RA BUCKNER CD RADICH J STORER B BENSINGER WI SOLL E ANASETTI C BOWDEN R BRYANT E CHAUNCEY T DEEG HJ DONEY KC FLOWERS M GOOLEY T HANSEN JA MARTIN PJ MCDONALD GB NASH R PETERSDORF EW SANDERS JE SCHOCH G STEWART P STORB R SULLIVAN KM THOMAS ED WITHERSPOON RP APPELBAUM FR
Citation: Jt. Slattery et al., MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION, Blood, 89(8), 1997, pp. 3055-3060
CYCLOSPORINE OR CYCLOSPORINE PLUS METHYLPREDNISOLONE FOR PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE - A PROSPECTIVE, RANDOMIZED TRIAL
Authors: DEEG HJ LIN DY LEISENRING W BOECKH M ANASETTI C APPELBAUM FR CHAUNCEY TR DONEY K FLOWERS M MARTIN P NASH R SCHOCH G SULLIVAN KM WITHERSPOON RP STORB R
Citation: Hj. Deeg et al., CYCLOSPORINE OR CYCLOSPORINE PLUS METHYLPREDNISOLONE FOR PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE - A PROSPECTIVE, RANDOMIZED TRIAL, Blood, 89(10), 1997, pp. 3880-3887
LONG-TERM FOLLOW-UP OF ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITHAPLASTIC-ANEMIA CONDITIONED BY CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN
Authors: STORB R LEISENRING W ANASETTI C APPELBAUM FR BUCKNER CD BENSINGER WI CHAUNCEY T CLIFT RA DEEG HJ DONEY KC FLOWERS MED HANSEN JA MARTIN PJ SANDERS KM WITHERSPOON RP
Citation: R. Storb et al., LONG-TERM FOLLOW-UP OF ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITHAPLASTIC-ANEMIA CONDITIONED BY CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN, Blood, 89(10), 1997, pp. 3890-3891
IMPROVED RECONSTITUTION OF CD4 T-CELLS AND B-CELLS BUT WORSENED RECONSTITUTION OF SERUM IGG LEVELS AFTER ALLOGENEIC TRANSPLANTATION OF BLOOD STEM-CELLS INSTEAD OF MARROW
Authors: STOREK J WITHERSPOON RP MALONEY DG CHAUNCEY TR STORB R
Citation: J. Storek et al., IMPROVED RECONSTITUTION OF CD4 T-CELLS AND B-CELLS BUT WORSENED RECONSTITUTION OF SERUM IGG LEVELS AFTER ALLOGENEIC TRANSPLANTATION OF BLOOD STEM-CELLS INSTEAD OF MARROW, Blood, 89(10), 1997, pp. 3891-3893
RECONSTITUTION OF MEMBRANE IGD(-) (MIGD(-)) B-CELLS AFTER MARROW TRANSPLANTATION LAGS BEHIND THE RECONSTITUTION OF MIGD(-CELLS() B)
Authors: STOREK J WITHERSPOON RP STORB R
Citation: J. Storek et al., RECONSTITUTION OF MEMBRANE IGD(-) (MIGD(-)) B-CELLS AFTER MARROW TRANSPLANTATION LAGS BEHIND THE RECONSTITUTION OF MIGD(-CELLS() B), Blood, 89(1), 1997, pp. 350-351
ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME WITH ADVANCED DISEASE MORPHOLOGY - A PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: ANDERSON JE APPELBAUM FR SCHOCH G GOOLEY T ANASETTI C BENSINGER WI BRYANT E BUCKNER CD CHAUNCEY T CLIFT RA DEEG HJ DONEY K FLOWERS M HANSEN JA MARTIN PJ MATTHEWS DC NASH RA SANDERS JE SHULMAN H SULLIVAN KM WITHERSPOON RP STORB R
Citation: Je. Anderson et al., ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME WITH ADVANCED DISEASE MORPHOLOGY - A PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION AND ANALYSIS OF PROGNOSTIC FACTORS, Journal of clinical oncology, 14(1), 1996, pp. 220-226
LACK OF B-CELL PRECURSORS IN MARROW TRANSPLANT RECIPIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: STOREK J WITHERSPOON RP WEBB D STORB R
Citation: J. Storek et al., LACK OF B-CELL PRECURSORS IN MARROW TRANSPLANT RECIPIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE, American journal of hematology, 52(2), 1996, pp. 82-89
EVALUATION OF A CD5-SPECIFIC IMMUNOTOXIN FOR TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION
Authors: MARTIN PJ NELSON BJ APPELBAUM FR ANASETTI C DEEG HJ HANSEN JA MCDONALD GB NASH RA SULLIVAN KM WITHERSPOON RP SCANNON PJ FRIEDMANN N STORB R
Citation: Pj. Martin et al., EVALUATION OF A CD5-SPECIFIC IMMUNOTOXIN FOR TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION, Blood, 88(3), 1996, pp. 824-830
LONG-TERM OUTCOME AND QUALITY-OF-LIFE AFTER MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA
Authors: DEEQ HJ LEISENRING W NIMS J FLOWERS M WITHERSPOON RP STORB R SULLIVAN KM
Citation: Hj. Deeq et al., LONG-TERM OUTCOME AND QUALITY-OF-LIFE AFTER MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA, Blood, 88(10), 1996, pp. 2560-2560
ALLOGENEIC MARROW TRANSPLANTATION FOR REFRACTORY-ANEMIA - A COMPARISON OF 2 PREPARATIVE REGIMENS AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: ANDERSON JE APPELBAUM FR SCHOCH G GOOLEY T ANASETTI C BENSINGER WI BRYANT E BUCKNER CD CHAUNCEY TR CLIFT RA DONEY K FLOWERS M HANSEN JA MARTIN PJ MATTHEWS DC SANDERS JE SHULMAN H SULLIVAN KM WITHERSPOON RP STORB R
Citation: Je. Anderson et al., ALLOGENEIC MARROW TRANSPLANTATION FOR REFRACTORY-ANEMIA - A COMPARISON OF 2 PREPARATIVE REGIMENS AND ANALYSIS OF PROGNOSTIC FACTORS, Blood, 87(1), 1996, pp. 51-58
MALIGNANCIES AFTER MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA AND FANCONI-ANEMIA - A JOINT SEATTLE AND PARIS ANALYSIS OF RESULTS IN 700 PATIENTS
Authors: DEEG HJ SOCIE G SCHOCH G HENRYAMAR M WITHERSPOON RP DEVERGIE A SULLIVAN KM GLUCKMAN E STORB R
Citation: Hj. Deeg et al., MALIGNANCIES AFTER MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA AND FANCONI-ANEMIA - A JOINT SEATTLE AND PARIS ANALYSIS OF RESULTS IN 700 PATIENTS, Blood, 87(1), 1996, pp. 386-392
T-CELL RECONSTITUTION AFTER BONE-MARROW TRANSPLANTATION INTO ADULT PATIENTS DOES NOT RESEMBLE T-CELL DEVELOPMENT IN EARLY-LIFE
Authors: STOREK J WITHERSPOON RP STORB R
Citation: J. Storek et al., T-CELL RECONSTITUTION AFTER BONE-MARROW TRANSPLANTATION INTO ADULT PATIENTS DOES NOT RESEMBLE T-CELL DEVELOPMENT IN EARLY-LIFE, Bone marrow transplantation, 16(3), 1995, pp. 413-425
LOW IGG PRODUCTION BY MONONUCLEAR-CELLS FROM MARROW TRANSPLANT SURVIVORS AND FROM NORMAL NEONATES IS DUE TO A DEFECT OF B-CELLS
Authors: STOREK J WITHERSPOON RP LUTHY D STORB R
Citation: J. Storek et al., LOW IGG PRODUCTION BY MONONUCLEAR-CELLS FROM MARROW TRANSPLANT SURVIVORS AND FROM NORMAL NEONATES IS DUE TO A DEFECT OF B-CELLS, Bone marrow transplantation, 15(5), 1995, pp. 679-684
A TOXICITY STUDY OF TRIMETREXATE USED IN COMBINATION WITH CYCLOSPORINE AS ACUTE GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN HLA-MISMATCHED, RELATED DONOR BONE-MARROW TRANSPLANTS
Authors: DONEY KC STORB R BEACH K ANASETTI C DEEG HJ HANSEN JA MARTIN PJ NASH RA SCHUBERT MM SULLIVAN KM WITHERSPOON RP APPELBAUM FR
Citation: Kc. Doney et al., A TOXICITY STUDY OF TRIMETREXATE USED IN COMBINATION WITH CYCLOSPORINE AS ACUTE GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN HLA-MISMATCHED, RELATED DONOR BONE-MARROW TRANSPLANTS, Transplantation, 60(1), 1995, pp. 55-58
LONG-TERM ADMINISTRATION OF INTRAVENOUS IMMUNOGLOBIN (IVIG) TO PREVENT LATE INFECTION AND CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING MARROW TRANSPLANTATION - CLINICAL OUTCOME AND EFFECT ON SUBSEQUENT IMMUNE RECOVERY
Authors: SULLIVAN KM STOREK J KOPECKY KJ JOCOM J LONGTON G WITHERSPOON RP BOWDEN R APPLEBAUM FR STORB R
Citation: Km. Sullivan et al., LONG-TERM ADMINISTRATION OF INTRAVENOUS IMMUNOGLOBIN (IVIG) TO PREVENT LATE INFECTION AND CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING MARROW TRANSPLANTATION - CLINICAL OUTCOME AND EFFECT ON SUBSEQUENT IMMUNE RECOVERY, Blood, 86(10), 1995, pp. 1824-1824
POST-BONE MARROW TRANSPLANT T-CELLS - ACTIVATED BUT RENDERED ANERGIC
Authors: STOREK J WITHERSPOON RP STORB R
Citation: J. Storek et al., POST-BONE MARROW TRANSPLANT T-CELLS - ACTIVATED BUT RENDERED ANERGIC, Journal of cellular biochemistry, 1994, pp. 449-449
MARROW TRANSPLANT EXPERIENCE FOR CHILDREN WITH SEVERE APLASTIC-ANEMIA
Authors: SANDERS JE STORB R ANASETTI C DEEG HJ DONEY K SULLIVAN KM WITHERSPOON RP HANSEN J
Citation: Je. Sanders et al., MARROW TRANSPLANT EXPERIENCE FOR CHILDREN WITH SEVERE APLASTIC-ANEMIA, The American journal of pediatric hematology/oncology, 16(1), 1994, pp. 43-49
SECONDARY MALIGNANCIES AFTER MARROW TRANSPLANTATION FOR LEUKEMIA OR APLASTIC-ANEMIA
Authors: WITHERSPOON RP DEEG HJ STORB R
Citation: Rp. Witherspoon et al., SECONDARY MALIGNANCIES AFTER MARROW TRANSPLANTATION FOR LEUKEMIA OR APLASTIC-ANEMIA, Transplantation, 57(10), 1994, pp. 1413-1418
MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - A RANDOMIZED STUDY COMPARING CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE
Authors: CLIFT RA BUCKNER CD THOMAS ED BENSINGER WI BOWDEN R BRYANT E DEEG HJ DONEY KC FISHER LD HANSEN JA MARTIN P MCDONALD GB SANDERS JE SCHOCH G SINGER J STORB R SULLIVAN KM WITHERSPOON RP APPELBAUM FR
Citation: Ra. Clift et al., MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - A RANDOMIZED STUDY COMPARING CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE, Blood, 84(6), 1994, pp. 2036-2043
Risultati: 1-25 | 26-32